CD4 and COVID-19: Although few differences between groups were observed based on immunophenotyping, we observed increases in antigen-specific CD4+ T cell responses to the SARS-CoV-2 S-protein in COVID-19 patients with prolonged symptom duration at the late convalescent time point.